Cheng-Ping Yu
Overview
Explore the profile of Cheng-Ping Yu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
100
Citations
1225
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ming H, Tan J, Cao S, Yu C, Qi Y, Wang C, et al.
Nat Metab
. 2025 Jan;
7(1):120-136.
PMID: 39753713
Nutrient availability strongly affects intestinal homeostasis. Here, we report that low-protein (LP) diets decrease amino acids levels, impair the DNA damage response (DDR), cause DNA damage and exacerbate inflammation in...
2.
Lin S, Yu C, Tsai J, Shyong Y
Mater Today Bio
. 2024 Sep;
28:101244.
PMID: 39318378
Glioma is a common primary malignant brain tumor with low survival rate. Immunotherapy with immune checkpoints inhibitors (ICI) can be a choice for glioma management, and extracellular vesicles (EVs) are...
3.
Lin T, Chung H, Jian M, Chang C, Perng C, Liao G, et al.
J Med Internet Res
. 2024 Sep;
26:e56022.
PMID: 39231422
Background: Breast cancer is a leading global health concern, necessitating advancements in recurrence prediction and management. The development of an artificial intelligence (AI)-based clinical decision support system (AI-CDSS) using ChatGPT...
4.
Yu K, Wu I, Yu C, Wang W, Chi C, Tsai K, et al.
Eur J Pharmacol
. 2024 Jun;
977:176682.
PMID: 38823759
The major limitation of cancer treatment is multidrug resistance (MDR), which leads to the inactivation of chemotherapeutic drugs and greater than 90% mortality. To solve this ordeal, we applied ligand-based...
5.
Yu C, Lin S, Tsai J, Shyong Y
Eur J Pharm Biopharm
. 2024 Feb;
197:114231.
PMID: 38382724
Temozolomide (TMZ) is the first line chemotherapy for glioblastoma (GBM) treatment, but the P-glycoprotein (P-gp) expressed in blood-brain barrier (BBB) will pump out TMZ from the brain leading to decreased...
6.
Li C, Wu T, Zhao X, Yu C, Wang Z, Zhou X, et al.
Front Bioeng Biotechnol
. 2023 Feb;
11:1052607.
PMID: 36845170
Exogenous insulin therapy is the mainstay treatment for Type-1 diabetes (T1D) caused by insulin deficiency. A fine-tuned insulin supply system is important to maintain the glucose homeostasis. In this study,...
7.
Lee M, Yu C, Chen X, Liu M, Yang J, Chen A, et al.
Front Cell Infect Microbiol
. 2022 Oct;
12:998584.
PMID: 36189352
Background: Non-structural protein 1 (NS1), one of the viral proteins of influenza A viruses (IAVs), plays a crucial role in evading host antiviral immune response. It is known that the...
8.
Huang C, Dai M, Kao C, Tsai W, Yu C
Medicina (Kaunas)
. 2022 Jul;
58(7).
PMID: 35888619
Oncocytic adrenal cortical neoplasms are rare cases and are divided into oncocytoma, oncocytic neoplasms of uncertain malignant potential and oncocytic adrenal cortical carcinomas, based on the Lin-Weiss-Bisceglia (LWB) histological system...
9.
Wang C, Lee Y, Khalil M, Lin K, Yu C, Lien H
Sci Rep
. 2022 Jul;
12(1):11623.
PMID: 35803996
Joint analysis of multiple protein expressions and tissue morphology patterns is important for disease diagnosis, treatment planning, and drug development, requiring cross-staining alignment of multiple immunohistochemical and histopathological slides. However,...
10.
Huang C, Tsai C, Yu C, Wu Y, Yee M, Ho J, et al.
Cancers (Basel)
. 2022 Feb;
14(4).
PMID: 35205713
Bladder cancer progression and metastasis have become major threats in clinical practice, increasing mortality and therapeutic refractoriness; recently, epigenetic dysregulation of epithelial-to-mesenchymal transition (EMT)-related signaling pathways has been explored. However,...